Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guntram Büsche

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Haematologica|August 5, 2018
Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment conceptsPeter Valent, Guntram Büsche, Igor Theurl, et al.
Cell Stem Cell|May 2, 2017
Gli1<sup>+</sup> Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic TargetRebekka K Schneider, Ann Mullally, Aurelien Dugourd, et al.
Oncotarget|February 15, 2011
Standards and impact of hematopathology in myelodysplastic syndromes (MDS)Peter Valent, Attilio Orazi, Guntram Büsche, et al.
Annals of Hematology|April 5, 2017
Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trialFriederike Braulke, Xenia Schulz, Ulrich Germing, et al.
Annals of Hematology|January 17, 2009
Meeting report: Vienna 2008 Workshop of the German-Austrian Working Group for Studying Prognostic Factors in Myelodysplastic SyndromesPeter Valent, Wolf-Karsten Hofmann, Guntram Büsche, et al.
Nature Medicine|February 16, 2016
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9Rebekka K Schneider, Monica Schenone, Monica Ventura Ferreira, et al.
Blood|July 30, 2020
Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPNHélène F E Gleitz, Aurélien J F Dugourd, Nils B Leimkühler, et al.
Annals of Hematology|April 27, 2021
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)Anna Hecht, Julia A Meyer, Johann-Christoph Jann, et al.
Cell Stem Cell|December 10, 2020
Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axisNils B Leimkühler, Hélène F E Gleitz, Li Ronghui, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Haematologica|August 5, 2018
Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment conceptsPeter Valent, Guntram Büsche, Igor Theurl, et al.
Cell Stem Cell|May 2, 2017
Gli1<sup>+</sup> Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic TargetRebekka K Schneider, Ann Mullally, Aurelien Dugourd, et al.
Oncotarget|February 15, 2011
Standards and impact of hematopathology in myelodysplastic syndromes (MDS)Peter Valent, Attilio Orazi, Guntram Büsche, et al.
Annals of Hematology|April 5, 2017
Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trialFriederike Braulke, Xenia Schulz, Ulrich Germing, et al.
Annals of Hematology|January 17, 2009
Meeting report: Vienna 2008 Workshop of the German-Austrian Working Group for Studying Prognostic Factors in Myelodysplastic SyndromesPeter Valent, Wolf-Karsten Hofmann, Guntram Büsche, et al.
Nature Medicine|February 16, 2016
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9Rebekka K Schneider, Monica Schenone, Monica Ventura Ferreira, et al.
Blood|July 30, 2020
Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPNHélène F E Gleitz, Aurélien J F Dugourd, Nils B Leimkühler, et al.
Annals of Hematology|April 27, 2021
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)Anna Hecht, Julia A Meyer, Johann-Christoph Jann, et al.
Cell Stem Cell|December 10, 2020
Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axisNils B Leimkühler, Hélène F E Gleitz, Li Ronghui, et al.
Pageof 6